I came across this site via a search on “superbugs” on Google News. The UK review team was commissioned by the UK Prime Minister in July 2014, and published its first report about 2 weeks ago. By the end of 2 years – summer 2016 – the Review will have to propose a package of actions that should be agreed upon internationally in order to contain the threat of antimicrobial resistance.
Their first paper – on the impact of antimicrobial resistance – is available for download online here. The main take home message of the first review is that by 2050, if the trajectory of antimicrobial resistance is not reversed:
- There will be 10 million deaths each year that is attributable to antimicrobial resistance.
- A reduction in global GDP by 2% – 3.5%, amounting up to USD100 trillion dollars.
The economic and mortality estimates were put together by two multi-disciplinary teams from RAND Europe and KPMG commissioned by the Review. Social and healthcare costs were unfortunately not assessed.
It is important to note that “antimicrobial resistance” here has been more broadly defined to include HIV, tuberculosis and malaria in addition to three of the usual drug-resistant bacteria – Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.